Comparison of minimal residual disease as outcome predictor for AML patients in first complete remission undergoing myeloablative or nonmyeloablative allogeneic hematopoietic cell transplantation
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Comparison of minimal residual disease as outcome predictor for AML patients in first complete remission undergoing myeloablative or nonmyeloablative allogeneic hematopoietic cell transplantation
Authors
Keywords
-
Journal
LEUKEMIA
Volume 29, Issue 1, Pages 137-144
Publisher
Springer Nature
Online
2014-06-03
DOI
10.1038/leu.2014.173
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Similar Overall Survival Using Sibling, Unrelated Donor, and Cord Blood Grafts after Reduced-Intensity Conditioning for Older Patients with Acute Myelogenous Leukemia
- (2013) Régis Peffault de Latour et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- How I assess comorbidities before hematopoietic cell transplantation
- (2013) M. L. Sorror BLOOD
- Significance of minimal residual disease before myeloablative allogeneic hematopoietic cell transplantation for AML in first and second complete remission
- (2013) R. B. Walter et al. BLOOD
- Achieving stringent CR is essential before reduced-intensity conditioning allogeneic hematopoietic cell transplantation in AML
- (2013) C Ustun et al. BONE MARROW TRANSPLANTATION
- Long-term survival after allogeneic haematopoietic cell transplantation for AML in remission: single-centre results after TBI-based myeloablative and non-myeloablative conditioning
- (2013) H Sengeløv et al. BONE MARROW TRANSPLANTATION
- Long-term survival with low toxicity after allogeneic transplantation for acute myeloid leukaemia and myelodysplasia using non-myeloablative conditioning without T cell depletion
- (2013) Jeff K. Davies et al. BRITISH JOURNAL OF HAEMATOLOGY
- Detectable minimal residual disease before hematopoietic cell transplantation is prognostic but does not preclude cure for children with very-high-risk leukemia
- (2012) W. Leung et al. BLOOD
- Comparison of conditioning regimens of various intensities for allogeneic hematopoietic SCT using HLA-identical sibling donors in AML and MDS with
- (2012) R Martino et al. BONE MARROW TRANSPLANTATION
- Prognostic and therapeutic implications of minimal residual disease at the time of transplantation in acute leukemia
- (2012) S A Buckley et al. BONE MARROW TRANSPLANTATION
- Impact of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation for acute myeloid leukemia: a report from the Acute Leukemia Working Party of the European group for blood and marrow transplantation
- (2012) F Baron et al. LEUKEMIA
- The European LeukemiaNet AML Working Party consensus statement on allogeneic HSCT for patients with AML in remission: an integrated-risk adapted approach
- (2012) Jan J. Cornelissen et al. Nature Reviews Clinical Oncology
- Concise Review: The Role of Hematopoietic Stem Cell Transplantation in the Treatment of Acute Myeloid Leukemia
- (2012) Betty K. Hamilton et al. STEM CELLS
- High success rate of hematopoietic cell transplantation regardless of donor source in children with very high-risk leukemia
- (2011) W. Leung et al. BLOOD
- Prognostic impact of discordant results from cytogenetics and flow cytometry in patients with acute myeloid leukemia undergoing hematopoietic cell transplantation
- (2011) Min Fang et al. CANCER
- Impact of Pretransplantation Minimal Residual Disease, As Detected by Multiparametric Flow Cytometry, on Outcome of Myeloablative Hematopoietic Cell Transplantation for Acute Myeloid Leukemia
- (2011) Roland B. Walter et al. JOURNAL OF CLINICAL ONCOLOGY
- Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials
- (2010) D. Grimwade et al. BLOOD
- Long-term disease-free survival after nonmyeloablative cyclophosphamide/fludarabine conditioning and related/unrelated allotransplantation for acute myeloid leukemia/myelodysplasia
- (2010) R P Nelson et al. BONE MARROW TRANSPLANTATION
- Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation in Patients With Acute Myeloid Leukemia
- (2010) Boglarka Gyurkocza et al. JOURNAL OF CLINICAL ONCOLOGY
- Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
- (2009) H. Dohner et al. BLOOD
- The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
- (2009) J. W. Vardiman et al. BLOOD
- HighWT1gene expression before haematopoietic stem cell transplant in children with acute myeloid leukaemia predicts poor event-free survival
- (2009) David A. Jacobsohn et al. BRITISH JOURNAL OF HAEMATOLOGY
- Toward Optimization of Postremission Therapy for Residual Disease–Positive Patients With Acute Myeloid Leukemia
- (2008) Luca Maurillo et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More